Skoči na glavni sadržaj

Stručni rad

PROPHYLAXIS OF MIGRAINE – A REVIEW OF LITERATURE

ANA ĆURKOVIĆ KATIĆ ; Klinički bolnički centar Split, Klinika za neurologiju, Split, Hrvatska
MARIO MIHALJ ; Klinički bolnički centar Split, Klinika za neurologiju i Sveučilište u Splitu, Medicinski fakultet, Split, Hrvatska
ANA REPIĆ BULIČIĆ ; Klinički bolnički centar Split, Klinika za neurologiju, Split, Hrvatska
MARTINA VIDOVIĆ ; Klinički bolnički centar Split, Klinika za neurologiju, Split, Hrvatska
MARINA TITLIĆ ; Klinički bolnički centar Split, Klinika za neurologiju i Sveučilište u Splitu, Medicinski fakultet, Split, Hrvatska


Puni tekst: hrvatski pdf 104 Kb

str. 83-88

preuzimanja: 517

citiraj


Sažetak

This literature review is aimed at assessing the possibilities of migraine prophylaxis. The International Headache Society (IHS) recommends performing migraine prophylaxis in patients suffering ≥4 migraine headaches per month, either episodic or chronic. The treatment is deemed successful when the migraine attacks are decreased by ≥50%. Effi ciency has been demonstrated for β-blockers, calcium antagonists, antiepileptics such as topiramate and valproate, as well as gabapentin, pregabalin, fl unarizine and antidepressants. The effi ciency of levetiracetam, cervical myofascial anesthesia, skin electrostimulation and muscular stimulation is still being tested. The effects of botulinum toxin are dubious. There is ongoing research of the possibility of using histamines, closing foramen ovale, acupuncture, supraorbital and vagal nerve stimulation and transcranial magnetic stimulation. Effects of catecholamine, melatonin, contraceptives, ribofl avin, dextromethorphan and melatonin in persisting migraine headaches are being researched as well. Required is an appropriate assessment of the possible effects of probiotics, coenzyme q10 and magnesium in migraine prophylaxis. Clinical researches have shown the use of human monoclonal antibodies erenumab, fremanezumab and galcanezumab to demonstrate a statistically signifi cant effi ciency (≥50%) in migraine prophylaxis, yet requiring further confi rmation in clinical practice.

Ključne riječi

prophylaxis; migraine; efficiency

Hrčak ID:

237934

URI

https://hrcak.srce.hr/237934

Datum izdavanja:

24.4.2020.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.680 *